Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Apr 2024 for Deciphera Pharmaceuticals, Inc., €452.
Filing timeline
BuySaleBrightstar Associates LLC
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brightstar Associates LLC: trading record in brief
Brightstar Associates LLC discloses dealings in Deciphera Pharmaceuticals, Inc. to SEC (Form 4). Between 2 October 2017 and 22 April 2024, the trades on record add up to 6 filings.
The open-market record is one-sided, with 2 purchases worth €41.7M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants.
The newest entry dates from 24 April 2024: a share grant of €452, in Deciphera Pharmaceuticals, Inc. The last purchase on record was published on 24 January 2023, which is 1,369 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brightstar Associates LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
48,136 shares@ US$0.010.0% of flowCommon StockSEC:0001493152-24-015800:0
914,001 shares@ US$0.010.0% of flowCommon StockSEC:0001493152-24-005709:0
2,427,693 shares@ US$0.010.1% of flowCommon StockSEC:0000899243-23-006583:0
1,666,666 shares@ US$18.0066.2% of flowCommon StockSEC:0000899243-23-002482:0
Canonical exit: 24 Apr 2023 (T+90)
1,478,978 shares@ US$10.0033.8% of flowCommon StockSEC:0000899243-22-016029:0
Canonical exit: 28 Jul 2022 (T+90)
5 of 5 declarations
